Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Phase II Study of Stereotactic Magnetic Resonance Imaging (MRI) Guided On-table Adaptive Radiation Therapy (SMART) for Patients With Borderline or Inoperable Locally Advanced Pancreatic Cancer

NCT03621644 is registered in ClinicalTrials.gov with Viewray Inc. as lead sponsor.

NCT NCT03621644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03621644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Phase II Study of Stereotactic Magnetic Resonance Imaging (MRI) Guided On-table Adaptive Radiation Therapy (SMART) for Patients With Borderline or Inoperable Locally Advanced Pancreatic Cancer
Lead sponsor
Viewray Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 1, 2019
Completion date
January 31, 2027
Enrollment
133 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer